Screener
Inhibrx Biosciences, Inc. INBX Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Inhibrx Biosciences, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026. Open the filing →
- Filed
- May 14, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0002007919-26-000027
FAQ
- What is Inhibrx Biosciences, Inc.'s current ratio?
- Inhibrx Biosciences, Inc. (INBX) reported current ratio of 6.5× in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s current ratio changed year-over-year?
- Inhibrx Biosciences, Inc.'s current ratio increased by 26.3% year-over-year, from 5.1× to 6.5×.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s current ratio?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s current ratio has grown at a -13.4% compound annual growth rate (CAGR), from 5.2× to 3.9×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Inhibrx Biosciences, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude